Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    Discover Pharma thrilled to be a media partner at CPHI Frankfurt 2025

    At not even six months old, the small team at [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    New Phesi data shows more than 100 diseases being studied with GLP-1 therapies

    Analysis highlights potential for benefits far beyond obesity, signalling a [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    CPHI Frankfurt’s puts spotlight on innovation, partnerships and sustainability – an interview with event director, Tara Dougal

    As CPHI Frankfurt 2025 prepares to welcome more than 60,000 [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Uncategorised

    CPHI Frankfurt 2025 set to welcome more than 60,000 global pharma professionals

    CPHI Frankfurt 2025 will bring the world’s pharmaceutical community back [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Cemiplimab plus chemotherapy shows five-year survival benefit in advanced NSCLC Empower-lung 3 trial

    Regeneron UK Limited has reported five-year follow-up results from the [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Symeres acquires DGr Pharma to enhance regulatory expertise and expand biopharma capabilities

    Symeres, a global contract research, development and manufacturing organization, has [...]

    May 5, 2026
  • Advanced Therapies,Drug Delivery & Formulation,Drug Discovery & Development

    Abselion launches AAVX and AAV9 total capsid quantification kits

    Abselion has expanded its product offering with the launch of [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    MRM Health raises €55 million to advance microbiome-based therapies for ulcerative colitis and beyond

    MRM Health, a clinical stage biopharmaceutical company developing microbiome-based therapeutics, [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Medable launches AI platform for clinical trials with monitoring tool CRA Agent

    Medable has launched Agent Studio, which it describes as the [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Lilly launches $1 billion TuneLab AI platform to boost biotech drug discovery

    Eli Lilly and Company has launched TuneLab, a new artificial [...]

    May 5, 2026
Previous535455Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • BlueWind wins FDA clearance for longer-lasting Revi implant for urinary incontinence
    Categories: Clinical & Regulatory, Medical devices, Therapeutic Areas
  • AI virtual screening tool boosts hit rate 100-fold on challenging drug targets
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
  • FDA backs registration pathway for Obsidian’s melanoma TIL therapy
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top